EP1192278A4 - 48 menschliche sekretierte proteine - Google Patents
48 menschliche sekretierte proteineInfo
- Publication number
- EP1192278A4 EP1192278A4 EP00937977A EP00937977A EP1192278A4 EP 1192278 A4 EP1192278 A4 EP 1192278A4 EP 00937977 A EP00937977 A EP 00937977A EP 00937977 A EP00937977 A EP 00937977A EP 1192278 A4 EP1192278 A4 EP 1192278A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13863199P | 1999-06-11 | 1999-06-11 | |
US138631P | 1999-06-11 | ||
PCT/US2000/014963 WO2000077256A1 (en) | 1999-06-11 | 2000-06-01 | 48 human secreted proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1192278A1 EP1192278A1 (de) | 2002-04-03 |
EP1192278A4 true EP1192278A4 (de) | 2003-05-28 |
Family
ID=22482904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00937977A Withdrawn EP1192278A4 (de) | 1999-06-11 | 2000-06-01 | 48 menschliche sekretierte proteine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1192278A4 (de) |
JP (1) | JP2003502058A (de) |
AU (1) | AU5308200A (de) |
CA (1) | CA2382185A1 (de) |
WO (1) | WO2000077256A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US6689579B1 (en) | 1996-10-25 | 2004-02-10 | Human Genome Sciences, Inc. | Polynucleotides encoding neutrokine-α |
US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
US7220840B2 (en) | 2000-06-16 | 2007-05-22 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
PT2275449T (pt) | 2000-06-16 | 2016-12-27 | Human Genome Sciences Inc | Anticorpos que se ligam imunoespecificamente a blys |
US20030091565A1 (en) | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
US20070042361A1 (en) * | 2001-03-27 | 2007-02-22 | Rosen Craig A | Human secreted proteins |
CA2446734A1 (en) | 2001-05-24 | 2002-11-28 | Human Genome Sciences, Inc. | Antibodies against tumor necrosis factor delta (april) |
CA2446610A1 (en) * | 2001-06-06 | 2002-12-12 | Human Genome Sciences, Inc. | 20 human secreted proteins |
WO2003087364A1 (fr) * | 2002-04-16 | 2003-10-23 | Tanabe Seiyaku Co., Ltd. | Nouveau recepteur couple a la proteine g et son gene |
WO2004071379A2 (en) * | 2003-02-17 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y10 (p2y10) |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0665293A2 (de) * | 1994-01-26 | 1995-08-02 | Hamamatsu Photonics K.K. | Verfahren für die Sequenzierung von Nukleinsäuren |
WO1998017783A1 (en) * | 1996-10-23 | 1998-04-30 | Regents Of The University Of Michigan | Improved adenovirus vectors |
WO1998037184A1 (en) * | 1997-02-21 | 1998-08-27 | The Regents Of The University Of California | Leafy cotyledon1 genes and their uses |
WO1998054963A2 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
WO1999018208A1 (en) * | 1997-10-02 | 1999-04-15 | Human Genome Sciences, Inc. | 101 human secreted proteins |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776746A (en) * | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
-
2000
- 2000-06-01 EP EP00937977A patent/EP1192278A4/de not_active Withdrawn
- 2000-06-01 WO PCT/US2000/014963 patent/WO2000077256A1/en not_active Application Discontinuation
- 2000-06-01 AU AU53082/00A patent/AU5308200A/en not_active Abandoned
- 2000-06-01 JP JP2001503696A patent/JP2003502058A/ja not_active Withdrawn
- 2000-06-01 CA CA002382185A patent/CA2382185A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0665293A2 (de) * | 1994-01-26 | 1995-08-02 | Hamamatsu Photonics K.K. | Verfahren für die Sequenzierung von Nukleinsäuren |
WO1998017783A1 (en) * | 1996-10-23 | 1998-04-30 | Regents Of The University Of Michigan | Improved adenovirus vectors |
WO1998037184A1 (en) * | 1997-02-21 | 1998-08-27 | The Regents Of The University Of California | Leafy cotyledon1 genes and their uses |
WO1998054963A2 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
WO1999018208A1 (en) * | 1997-10-02 | 1999-04-15 | Human Genome Sciences, Inc. | 101 human secreted proteins |
Non-Patent Citations (7)
Title |
---|
DATABASE EMBL [online] 15 March 2000 (2000-03-15), XP002221505, Database accession no. AC025596 * |
DATABASE EMBL [online] 18 April 1997 (1997-04-18), XP002221504, Database accession no. AA340580 * |
DATABASE EMBL [online] 9 April 1998 (1998-04-09), XP002221506, Database accession no. AL022395 * |
DATABASE WPI Section Ch Week 199823, Derwent World Patents Index; Class B04, AN 1998-261485, XP002221508 * |
DATABASE WPI Section Ch Week 199905, Derwent World Patents Index; Class B04, AN 1999-059865, XP002218276 * |
DATABASE WPI Section Ch Week 199922, Derwent World Patents Index; Class B04, AN 1999-264022, XP002221507 * |
See also references of WO0077256A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2003502058A (ja) | 2003-01-21 |
AU5308200A (en) | 2001-01-02 |
EP1192278A1 (de) | 2002-04-03 |
CA2382185A1 (en) | 2000-12-21 |
WO2000077256A1 (en) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1218408A4 (de) | 32 menschliche, sekretierte proteine | |
EP1212343A4 (de) | 52 menschliche sekretierte proteine | |
EP1181390A4 (de) | 27 menschliche, sekretierte proteine | |
EP1224285A4 (de) | 27 menschliche sekretierte proteine | |
EP1212342A4 (de) | 18 human-sekretierte proteine | |
EP1226231A4 (de) | 19 humane sekretierte proteine | |
EP1175438A4 (de) | 62 humane sekretierte proteine | |
EP1192278A4 (de) | 48 menschliche sekretierte proteine | |
EP1192176A4 (de) | 49 menschliche sekretierte proteine | |
EP1175439A4 (de) | 49 humane sekretierte proteine | |
EP1165827A4 (de) | 45 humane sekretierte proteine | |
EP1159284A4 (de) | 33 human sekrteierte proteine | |
EP1189917A4 (de) | 48 menschliche sekretierte proteine | |
EP1185543A4 (de) | 50 human-sekretierte proteine | |
EP1224201A4 (de) | 32 vom menschen abgesonderte proteine | |
EP1173477A4 (de) | 49 humane sekretierte Proteine | |
EP1206573A4 (de) | 26 humane sekretionsproteine | |
EP1203005A4 (de) | 25 humane sekretierte proteine | |
EP1169332A4 (de) | 49 human sekrtierte proteine | |
EP1171460A4 (de) | 48 menschliche sekretierte proteine | |
EP1144614A4 (de) | Menschliche, ausgeschiedene proteine | |
EP1165602A4 (de) | 49 menschliche, sekretierte proteine | |
EP1165828A4 (de) | 50 menschliche sekretierte proteine | |
EP1185285A4 (de) | 49 humane sekretierte proteine | |
EP1228082A4 (de) | 29 humansekretierte proteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011228 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07H 21/02 A, 7C 07H 21/04 B, 7C 12N 1/20 B, 7C 12N 15/00 B, 7C 12N 15/09 B, 7C 12N 15/63 B, 7C 12N 15/70 B, 7C 12N 15/74 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030414 |
|
17Q | First examination report despatched |
Effective date: 20030702 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040513 |